Mecobalamin
Mecobalamin is a pharmaceutical drug with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy
Mecobalamin in Promoting Recurrent Laryngeal Nerve Function Recovery After Thyroid Surgery
Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury
Effects of Epalrestat on Peripheral Neuropathy and Central Nervous System in Diabetic Patients
Effect of Rotating Magnetic Therapy on Diabetic Peripheral Neuropathy
Clinical Trials (8)
Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy
Mecobalamin in Promoting Recurrent Laryngeal Nerve Function Recovery After Thyroid Surgery
Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury
Effects of Epalrestat on Peripheral Neuropathy and Central Nervous System in Diabetic Patients
Effect of Rotating Magnetic Therapy on Diabetic Peripheral Neuropathy
The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia.
Autologous Adipose Mesenchymal Stem Cell Transplantation in the Treatment of Patients With Hemifacial Spasm
Oral Vitamin B12 Administration for Vitamin B12 Deficiency After Total Gastrectomy
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8